Triażolam

Triazolam is a short-acting benzodiazepine of the triazolobenzodiazepine subclass, primarily used as a hypnotic agent for the short-term management of insomnia. It is distinguished by its notably brief half-life compared to many other benzodiazepines and does not produce active metabolites. At higher doses, it may induce significant amnesia and lowered inhibitions. Like all benzodiazepines, triazolam carries a risk of habit formation and dependence.

Also known as: Hypam, Trilam, Halcion, Novodorm, Up johns

Classification

Chemical: Benzodiazepine
Psychoactive: Depressant
Tag: Anxiolytic
Tag: GABAergic
Tag: Habit-Forming
Tag: Muscle Relaxant
Tag: Sedative

Effects

Respiratory Depression
Sedation
Muscle Relaxation
Anxiolytic
But Primarily Sedative Or Hypnotic
Anxiety Suppression
Amnesia
Motor Control Loss
Reduced Anxiety
Euphoria
Disinhibition
Dulled Perception

Routes of Administration

Oral

Dosage

Heavy: 1.5 mg
Light: 0.125 – 0.25 mg
Common: 0.25 – 0.5 mg
Strong: 0.5 – 1.5 mg
Threshold: 0.125 mg

Duration

Onset: 0.17-0.33 h
Peak: 1-1.5 h
After Effects: 1-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu